• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝病中的红细胞棘形红细胞增多症。异常血浆高密度脂蛋白的作用。

Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.

作者信息

Owen J S, Brown D J, Harry D S, McIntyre N, Beaven G H, Isenberg H, Gratzer W B

出版信息

J Clin Invest. 1985 Dec;76(6):2275-85. doi: 10.1172/JCI112237.

DOI:10.1172/JCI112237
PMID:4077979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC424351/
Abstract

Echinocytes were frequently found in patients with liver disease when their blood was examined in wet films, but rarely detected in dried, stained smears. When normal erythrocytes (discocytes) were incubated with physiologic concentrations of the abnormal high density lipoproteins (HDL) from some jaundiced patients, echinocytosis developed within seconds. Other plasma fractions were not echinocytogenic. There was a close correlation between the number of echinocytes found in vivo and the ability of the corresponding HDL to induce discocyte-echinocyte transformation. On incubation with normal HDL, echinocytes generated in vitro rapidly reverted to a normal shape, and echinocytes from patients showed a similar trend. Echinocytosis occurred without change in membrane cholesterol content, as did its reversal, and was not caused by membrane uptake of lysolecithin or bile acids. Abnormal, echinocytogenic HDL showed saturable binding to approximately 5,000 sites per normal erythrocyte with an association constant of 10(8) M-1. Nonechinocytogenic patient HDL and normal HDL showed only nonsaturable binding. Several minor components of electrophoretically separated erythrocyte membrane proteins bound the abnormal HDL; pretreatment of the cells with trypsin or pronase reduced or eliminated binding. Echinocytosis by abnormal HDL required receptor occupancy, rather than transfer of constituents to or from the membrane, because cells reversibly prefixed in the discoid shape by wheat germ agglutinin, and then exposed to abnormal HDL, did not become echinocytes when the HDL and lectin were successively removed. Binding did not cause dephosphorylation of spectrin. We conclude that the echinocytes of liver disease are generated from discocytes by abnormal HDL, and we infer that the shape change is mediated by cell-surface receptors for abnormal HDL molecules.

摘要

棘红细胞在肝病患者的湿片血液检查中经常被发现,但在干燥、染色涂片上很少被检测到。当正常红细胞(双凹圆盘状红细胞)与一些黄疸患者生理浓度的异常高密度脂蛋白(HDL)一起孵育时,几秒钟内就会出现棘红细胞增多现象。其他血浆成分没有诱导棘红细胞形成的作用。体内发现的棘红细胞数量与相应HDL诱导双凹圆盘状红细胞向棘红细胞转化的能力之间存在密切相关性。与正常HDL孵育时,体外产生的棘红细胞会迅速恢复正常形状,来自患者的棘红细胞也表现出类似趋势。棘红细胞增多现象发生时膜胆固醇含量没有变化,其逆转时也是如此,并且不是由溶血卵磷脂或胆汁酸的膜摄取引起的。异常的、能诱导棘红细胞形成的HDL与每个正常红细胞上约5000个位点表现出饱和结合,结合常数为10(8) M-1。不能诱导棘红细胞形成的患者HDL和正常HDL仅表现出非饱和结合。电泳分离的红细胞膜蛋白的几个次要成分与异常HDL结合;用胰蛋白酶或链霉蛋白酶预处理细胞会减少或消除这种结合。异常HDL引起的棘红细胞增多需要受体被占据,而不是成分向膜内或从膜内转移,因为用麦胚凝集素可逆地固定在双凹圆盘状形状的细胞,然后暴露于异常HDL,当HDL和凝集素相继去除时不会变成棘红细胞。结合不会导致血影蛋白去磷酸化。我们得出结论,肝病患者的棘红细胞是由异常HDL从双凹圆盘状红细胞产生的,并且我们推断这种形状变化是由异常HDL分子的细胞表面受体介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/f74434f52a6e/jcinvest00126-0257-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/28438e85bd98/jcinvest00126-0253-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/864e65d5018d/jcinvest00126-0254-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/857fac47def2/jcinvest00126-0254-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/67a4620b7cdc/jcinvest00126-0254-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/1ac8ec9f01b5/jcinvest00126-0254-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/1cb05d3ad9c8/jcinvest00126-0254-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/84f01a2fce63/jcinvest00126-0254-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/4bc9b1512801/jcinvest00126-0255-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/2ff565134e6c/jcinvest00126-0255-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/34106603c7f1/jcinvest00126-0255-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/6a614a76c7dd/jcinvest00126-0255-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/899cf7923918/jcinvest00126-0255-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/d3c94d171393/jcinvest00126-0255-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/d7dfa262b7be/jcinvest00126-0257-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/94faf0ced001/jcinvest00126-0257-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/c3245e530d79/jcinvest00126-0257-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/f74434f52a6e/jcinvest00126-0257-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/28438e85bd98/jcinvest00126-0253-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/864e65d5018d/jcinvest00126-0254-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/857fac47def2/jcinvest00126-0254-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/67a4620b7cdc/jcinvest00126-0254-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/1ac8ec9f01b5/jcinvest00126-0254-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/1cb05d3ad9c8/jcinvest00126-0254-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/84f01a2fce63/jcinvest00126-0254-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/4bc9b1512801/jcinvest00126-0255-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/2ff565134e6c/jcinvest00126-0255-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/34106603c7f1/jcinvest00126-0255-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/6a614a76c7dd/jcinvest00126-0255-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/899cf7923918/jcinvest00126-0255-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/d3c94d171393/jcinvest00126-0255-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/d7dfa262b7be/jcinvest00126-0257-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/94faf0ced001/jcinvest00126-0257-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/c3245e530d79/jcinvest00126-0257-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6716/424351/f74434f52a6e/jcinvest00126-0257-d.jpg

相似文献

1
Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.肝病中的红细胞棘形红细胞增多症。异常血浆高密度脂蛋白的作用。
J Clin Invest. 1985 Dec;76(6):2275-85. doi: 10.1172/JCI112237.
2
Erythrocyte spectrin alteration induced by low-density lipoprotein.低密度脂蛋白诱导的红细胞血影蛋白改变
J Supramol Struct. 1979;10(2):253-63. doi: 10.1002/jss.400100214.
3
[Hemolytic anemia caused by echinocytosis in liver cirrhosis].
Dtsch Med Wochenschr. 1988 Jan 22;113(3):91-5. doi: 10.1055/s-2008-1067599.
4
[A study of the abnormalities of HDL (high density lipoproteins) in liver diseases].
Fukuoka Igaku Zasshi. 1985 Aug;76(8):407-15.
5
[Changes in the lipid profile in chronic hepatopathies].[慢性肝病患者血脂谱的变化]
Med Clin (Barc). 1994 Mar 19;102(10):364-8.
6
In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease.肝病患者脂蛋白胆固醇酯代谢的体内评估。
Gastroenterology. 1983 Oct;85(4):820-9.
7
Rheological properties of blood in patients with chronic liver disease.
Clin Hemorheol Microcirc. 2002;26(1):9-14.
8
Serum lipoprotein patterns in liver and heart disease.肝脏和心脏疾病中的血清脂蛋白模式。
Ann Clin Lab Sci (1971). 1972 Sep-Oct;2(5):343-7.
9
[Serum lipoprotein fractions in chronic liver diseases with and without alcoholism].[伴有或不伴有酒精中毒的慢性肝病中的血清脂蛋白组分]
Boll Soc Ital Biol Sper. 1981 Aug 30;57(16):1692-7.
10
Observation of echinocytosis in eight patients: a phase contrast and SEM study.
Br J Haematol. 1978 Dec;40(4):519-26. doi: 10.1111/j.1365-2141.1978.tb05827.x.

引用本文的文献

1
Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?外周组织线粒体中NMDA受体介导的氧化应激是肝性脑病发病机制中的关键因素吗?
J Clin Med. 2022 Feb 4;11(3):827. doi: 10.3390/jcm11030827.
2
Single red blood cell analysis reveals elevated hemoglobin in poikilocytes.单个红细胞分析显示异形红细胞中血红蛋白升高。
J Biomed Opt. 2020 Jan;25(1):1-13. doi: 10.1117/1.JBO.25.1.015004.
3
Adapted Lethality: What We Can Learn from Guinea Pig-Adapted Ebola Virus Infection Model.

本文引用的文献

1
SPUR-CELL ANEMIA: HEMOLYTIC ANEMIA WITH RED CELLS RESEMBLING ACANTHOCYTES IN ALCOHOLIC CIRRHOSIS.棘形细胞贫血:酒精性肝硬化中伴有类似棘形红细胞的溶血性贫血。
N Engl J Med. 1964 Aug 20;271:396-8. doi: 10.1056/NEJM196408202710804.
2
The effect of cholesterol and other intercalated amphipaths on the contour and stability of the isolated red cell membrane.胆固醇及其他嵌入性两亲分子对分离的红细胞膜轮廓及稳定性的影响。
J Biol Chem. 1980 Oct 10;255(19):9331-7.
3
Stoichiometry of wheat germ agglutinin as a morphology controlling agent and as a morphology controlling agent and as a morphology protective agent for the human erythrocyte.
适应性致死率:我们能从豚鼠适应性埃博拉病毒感染模型中学到什么。
Adv Virol. 2016;2016:8059607. doi: 10.1155/2016/8059607. Epub 2016 Feb 18.
4
Poikilocytosis in rabbits: prevalence, type, and association with disease.家兔的异形红细胞增多症:患病率、类型及其与疾病的关联。
PLoS One. 2014 Nov 17;9(11):e112455. doi: 10.1371/journal.pone.0112455. eCollection 2014.
5
Elasto-plasticity in wrinkled polymerized lipid membranes.褶皱聚合脂质膜中的弹塑性
Sci Rep. 2014 Jan 15;4:3699. doi: 10.1038/srep03699.
6
New insight into erythrocyte through in vivo surface-enhanced Raman spectroscopy.通过体内表面增强拉曼光谱深入了解红细胞。
Biophys J. 2009 Dec 16;97(12):3206-14. doi: 10.1016/j.bpj.2009.09.029.
7
Ultrastructural study of echinocytes induced by poly (ethylene glycol)-cholesterol.聚(乙二醇)-胆固醇诱导棘红细胞的超微结构研究
Histochem Cell Biol. 2004 Dec;122(6):587-92. doi: 10.1007/s00418-004-0723-8. Epub 2004 Nov 18.
小麦胚凝集素作为人类红细胞形态控制剂和形态保护剂的化学计量学。
J Cell Biol. 1980 Jun;85(3):534-48. doi: 10.1083/jcb.85.3.534.
4
Effects of cholesterol on lipid organization in human erythrocyte membrane.胆固醇对人红细胞膜脂质组织的影响。
J Cell Biol. 1980 May;85(2):283-91. doi: 10.1083/jcb.85.2.283.
5
Rapid regulation of the activity of the low density lipoprotein receptor of cultured human fibroblasts.培养的人成纤维细胞低密度脂蛋白受体活性的快速调节
J Biol Chem. 1980 Jan 25;255(2):475-85.
6
Control of the erythrocyte membrane shape: recovery from the effect of crenating agents.红细胞膜形状的控制:从皱缩剂作用中恢复。
J Cell Biol. 1981 Dec;91(3 Pt 1):884-8. doi: 10.1083/jcb.91.3.884.
7
Platelet lipid composition and platelet aggregation in human liver disease.人类肝脏疾病中的血小板脂质组成与血小板聚集
J Lipid Res. 1981 Mar;22(3):423-30.
8
The solubility of amphipathic molecules in biological membranes and lipid bilayers and its implications for membrane structure.两亲性分子在生物膜和脂质双分子层中的溶解性及其对膜结构的影响。
Biochemistry. 1981 Feb 17;20(4):808-18. doi: 10.1021/bi00507a024.
9
Interaction of cholesterol and lysophosphatidylcholine in determining red cell shape.胆固醇与溶血磷脂酰胆碱在决定红细胞形状中的相互作用。
J Lipid Res. 1982 Nov;23(8):1121-7.
10
Role of the bilayer in the shape of the isolated erythrocyte membrane.双层膜在分离的红细胞膜形状中的作用。
J Membr Biol. 1982;69(2):113-23. doi: 10.1007/BF01872271.